Teens needed for First-Ever antibiotic safety study
NCT ID NCT07092813
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This early-stage study is testing whether a single dose of an experimental antibiotic combination (sulopenem etzadroxil plus probenecid) is safe and tolerable in 12 adolescents already receiving standard antibiotics for a bacterial infection. Researchers will measure how the drug moves through the body by collecting blood and urine samples over 12 hours. The goal is to gather safety and drug-level data to support future use in teens.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BACTERIAL INFECTION are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Medical facility
RECRUITINGLittle Rock, Arkansas, 72205, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can Weight-Loss surgery alter how medications work?
- Hospital care model aims to treat opioid addiction and serious infections together
- Study links NSAIDs to severe bacterial infections
- Transplant breakdown? new study checks organ fluid for hidden germs
- New pump lets kids get antibiotics at home, not hospital
- Healthy volunteers test two versions of experimental drug